Abstract B25: Using species-specific RNAseq reveals stromal reprogramming in triple-negative breast cancer xenografts

Triple Negative ◽

Species Specific ◽

Abstract 2835: Voruciclib, a clinical stage oral CDK inhibitor, sensitizes triple negative breast cancer xenografts to proteasome inhibition

10.1158/1538-7445.am2016-2835 ◽

2016 ◽

Cited By ~ 1

Author(s):

Joyoti Dey ◽

Joseph Casalini ◽

Sally Ditzler ◽

Matt Biery ◽

Angela Merrell ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Clinical Stage ◽

Proteasome Inhibition ◽

Cdk Inhibitor ◽

Abstract 2411: Evolution during propagation and treatment of patient-derived triple negative breast cancer xenografts

10.1158/1538-7445.am2016-2411 ◽

2016 ◽

Author(s):

Hyunsoo Kim ◽

Pooja Kumar ◽

Francesca Menghi ◽

Joshy George ◽

Guru Ananda ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Abstract B35: The role of tumor associated macrophages (TAMs) in triple-negative breast cancer (TNBC) invasion revealed by species-specific RNA sequencing

10.1158/1538-7445.chtme14-b35 ◽

2015 ◽

Author(s):

Daniel C. Rabe ◽

Casey A. Frankenberger ◽

Russell Bainer ◽

Devipriya Sankarasharma ◽

Kiran Chada ◽

...

Keyword(s):

Breast Cancer ◽

Rna Sequencing ◽

Triple Negative ◽

Tumor Associated Macrophages ◽

Species Specific

Abstract P1-03-09: Pegylated recombinant human hyaluronidase PH20 (PEGPH20) enhances efficacy of eribulin mesylate (HALAVEN®) in triple negative breast cancer xenografts

10.1158/1538-7445.sabcs15-p1-03-09 ◽

2016 ◽

Author(s):

JD Bahn ◽

C DesJardins ◽

KB Condon ◽

A Fathallah ◽

S Zimmerman ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Eribulin Mesylate ◽

Recombinant Human Hyaluronidase ◽

The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-12-0275-t ◽

2012 ◽

Vol 12 (2) ◽

pp. 131-140 ◽

Cited By ~ 25

Author(s):

Ezia Bello ◽

Giulia Taraboletti ◽

Gennaro Colella ◽

Massimo Zucchetti ◽

Daniele Forestieri ◽

...

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Triple Negative ◽

Kinase Inhibitor ◽

Advanced Stage ◽

Fangjihuangqi Decoction inhibits MDA‐MB‐231 cell invasion in vitro and decreases tumor growth and metastasis in triple‐negative breast cancer xenografts tumor zebrafish model

Cancer Medicine ◽

10.1002/cam4.2894 ◽

2020 ◽

Vol 9 (7) ◽

pp. 2564-2578 ◽

Cited By ~ 2

Author(s):

Yubo Guo ◽

Yingyi Fan ◽

Xiaohua Pei

Keyword(s):

Breast Cancer ◽

Tumor Growth ◽

Cell Invasion ◽

Triple Negative ◽

Zebrafish Model ◽

Tumor Growth And Metastasis ◽

Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and1H MR spectroscopy

Journal of Magnetic Resonance Imaging ◽

10.1002/jmri.24319 ◽

2013 ◽

Vol 39 (6) ◽

pp. 1588-1594 ◽

Cited By ~ 11

Author(s):

Guihua Zhai ◽

Hyunki Kim ◽

David Sarver ◽

Sharon Samuel ◽

Lee Whitworth ◽

...

Keyword(s):

Breast Cancer ◽

Mr Spectroscopy ◽

Diffusion Weighted Imaging ◽

Triple Negative ◽

Early Therapy ◽

Therapy Assessment ◽

Diffusion Weighted ◽

Combined treatment with p53-activating drug APR-246 and a phosphatidylserine-targeting antibody, 2aG4, inhibits growth of human triple-negative breast cancer xenografts

Cancer Reports and Reviews ◽

10.15761/crr.1000205 ◽

2020 ◽

Vol 4 (2) ◽

Author(s):

Yayun Liang ◽

Cynthia Besch-Williford ◽

Benford Mafuvadze ◽

Rolf A Brekken ◽

Salman M Hyder

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Combined Treatment ◽

Abstract 3449: Impact ofBRCA2mutation in primary human triple negative breast cancer xenografts on the responses to ionizing radiation andin vivotumor growth after treatment

10.1158/1538-7445.am2012-3449 ◽

2012 ◽

Author(s):

Frédéric Pouzoulet ◽

Franck Assayag ◽

Christophe Roulin ◽

Aurelie Thuleau ◽

Tomasz Zaremba ◽

...

Keyword(s):

Breast Cancer ◽

Ionizing Radiation ◽

Triple Negative ◽

Abstract C110: Applications of patient-derived triple-negative breast cancer xenografts that represent understudied patients in Louisiana in targeted therapeutic research

10.1158/1538-7755.disp18-c110 ◽

2020 ◽

Author(s):

Margarite D. Matossian ◽

Steven Elliott ◽

Hope E. Burks ◽

Maryl Wright ◽

Rachel A. Sabol ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Therapeutic Research ◽

Breast Cancer Xenografts ◽

Targeted Therapeutic